We are working with leading academic and clinical centres to develop cell specific polymeric substrates using our accelerate™ Technology.
These surfaces, capable of supporting the isolation and propagation of human cell lines, are being used to develop ethically favourable, dynamic, in-vitro test systems for modelling device behaviour and drug release kinetics.
The ability to control substrate surface chemistry to regulate cell behaviour is fundamental to the advancement of novel tissue engineering and regenerative medicine strategies in the development of cell therapies for serious diseases.
